Shruti Daga
Brentford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A randomized study of the safety and pharmacokinetics of GSK3358699, a mononuclear myeloid-targeted bromodomain and extra-terminal domain inhibitor.
Journal: British journal of clinical pharmacology
Published: April 30, 2021
Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study.
Journal: Annals of the rheumatic diseases
Published: October 04, 2017
Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial.
Journal: Journal of the American Heart Association
Published: January 13, 2017
Effects of the small molecule SIRT1 activator, SRT2104 on arterial stiffness in otherwise healthy cigarette smokers and subjects with type 2 diabetes mellitus.
Journal: Open heart
Published: January 13, 2016
Cardiovascular effects of a novel SIRT1 activator, SRT2104, in otherwise healthy cigarette smokers.
Journal: Journal of the American Heart Association
Published: June 18, 2013
GPIb VNTR C/C genotype may predict embolic events in infective endocarditis.
Journal: The Journal of heart valve disease
Published: April 25, 2013
Tyrosine phosphatase inhibitors combined with retinoic acid can enhance differentiation of neuroblastoma cells and trigger ERK- and AKT-dependent, p53-independent senescence.
Journal: Cancer letters
Published: December 09, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026